Cordierite formation during the experimental reaction of plagioclase with Mg-rich aqueous solutions

The reaction between plagioclase (labradorite and oligoclase) and Mg-rich aqueous solutions was studied experimentally at hydrothermal conditions (600–700 °C, 2 kbar). During the experiments, plagioclase grains were readily converted to cordierite and quartz within 4 days. The cordierite crystals had well-developed polyhedral shapes, but showed skeletal internal morphologies suggestingthat the initial growth occurred fast under high-driving-force conditions. In pure MgCl2 solutions (0.5–5 M), plagioclase dissolution and cordierite precipitation were spatially uncoupled indicating that Al was to some extent mobile in the fluid. Cordierite crystals formed at 700 °C showed orthorhombic symmetry, whereas those formed at 600 °C dominantly persisted in the metastable hexagonal form suggesting a strong increase in Al, Si ordering speed between 600 and 700 °C. The thermodynamic evolution of the fluid–solid system ultimately resulted in stabilization of Ca-rich plagioclase as demonstrated by partial anorthitization of unreacted plagioclase grains. Cordierite was also observed to form when Mg was added to a potentially albitizing Na-silicate-bearing solution. In that case, cordieriteprecipitation appeared to be more closely coupled to plagioclase dissolution, and secondary alteration of remnant plagioclase grains did not occur most likely due to armouring of the plagioclase by the cordierite overgrowth. The fast reaction rates observed in our experimental study have potential implications for Mg-metasomatism as a rockforming process

Medicinal mushrooms in prevention and control of diabetes mellitus

International audienceDiabetes mellitus is a life-threatening chronic metabolic disease caused by lack of insulin and/or insulin dysfunction, characterized by high levels of glucose in the blood (hyperglycemia). Millions worldwide suffer from diabetes and its complications. Significantly, it has been recognized that type 2 diabetes is an important preventable disease and can be avoided or delayed by lifestyle intervention. Presently, there are many chemical and biochemical hypoglycemic agents (synthetic drugs), that are used in treating diabetes and are effective in controlling hyperglycemia. However, as they may have harmful side-effects and fail to significantly alter the course of diabetic complications, natural anti-diabetic drugs from medicinal plants have attracted a great deal of attention. Medicinal mushrooms have been valued as a traditional source of natural bioactive compounds over many centuries and have been targeted as potential hypoglycemic and anti-diabetic agents. Bioactive metabolites including polysaccharides, proteins, dietary fibres, and many other biomolecules isolated from medicinal mushrooms and their cultured mycelia have been shownto be successful in diabetes treatment as biological antihyperglycemic agents. In this review we discuss the biological nature of diabetes and, in particular, explore some promising mushrooms that have experimental anti-diabetic properties, preventing or reducing the development of diabetes mellitus. The importance of medicinal mushrooms as agents of medical nutrition therapy and how their metabolites can be used as supportive candidates for prevention and control of diabetes is explored. Future prospects for this field of study and the difficulties and constraints that might affect the development of rational drug products from medicinal mushrooms are discussed